Zelira
Zelira Medicinal Cannabis Trial Enlists Retired AFL Players
Preliminary results from Zelira's trial have shown that cannabis may be able to replace morphine as a treatment option for severe chronic pain patients. The Australian cannabis co...
Zenivol™ launches in Australia after TGA adds to Special Access Scheme
Zelira steps into Australia to help those who suffer from Chronic Insomnia after a clinical trial boasts significant improvements. Zelira Therapeutics Ltd (ASX: ZLD) is pleased to...
Zelira Therapeutics: Latest Trends and Insights January 2020
Zelira Therapeutics Ltd (ASX: ZLD) is an Australian-based biopharmaceutical company that aims to treat important diseases and disorders using cannabinoid-based medicines. Formerly...
Zelira Collaborates With Parkinson's Foundation
In attempts to treat people with Parkinson's Disease through the use of cannabis, Zelira Therapeutics will be collaborating with the Parkinson's Foundation in America. Zelira Thera...
About Pot Stocks
Learn more about the biggest pot stocks making headlines. We provide a constant stream of breaking news, in-depth analysis, and valuable insight into the marijuana market.
Get Started
